Tesla officials concede process for going private just begun: Gasparino
Regulators probe Tesla
SEC ramps up Tesla investigation after Elon Musk's tweets
Tesla has reportedly been issued subpoenas by The Securities and Exchange Commission regarding its privatization plans.
SEC is formally investigating Tesla: Gasparino
SEC ramps up investigation into Tesla
Tesla SEC investigation ramps up
SEC investigating Tesla
Sen. Warren says companies should not be accountable only to shareholders
Sen. Warren comments on corporate accountability
Why would Elon Musk want to take Tesla private?
Bid to take Tesla private
Democratic Socialists: Nationalize health care and water down big business
This emerging group is even more left of the Democratic party on economic issues.
Musk tweet on possibly taking Tesla private sparks legal concerns
Tesla CEO and Twitter
One of the greatest problems in US is drug prices: Carl Icahn
Icahn on Cigna-Express deal
Cigna-Express Scripts deal just doesn’t make any sense: Carl Icahn
Icahn on Cigna-Express deal
Ford has no issues being a public company
Tesla’s Elon Musk has sparked a new debate about public markets.
Napolitano on Rep. Collins’ charges: This is classic insider trading
Rep. Collins indicted for insider trading
Rep. Chris Collins indicted for insider trading
Rep. Chris Collins indicted
This hedge fund’s trades are driven by artificial intelligence
Faceless robots may be the next wave for investors to manage your money.
6 factors to watch as the bull market pushes toward an endurance record
In just three weeks, it could become the longest bull run ever
Warren Buffett’s Berkshire Hathaway profit soars in second quarter
Earnings were boosted by insurance underwriting and an accounting change.
Fidelity to launch no-fee index funds
The move comes as asset managers have been pressured to lower costs.
American Express sneakily raised rates on biz clients without notice: report
The company is said to have recruited businesses by offering low currency-conversion rates, without disclosing that those rates were subject to increase.
Merck reports strong quarterly earnings, boosted by cancer drug
Drugmaker Merck & Co (MRK.N) topped Wall Street estimates for quarterly profit on Friday as sales of blockbuster cancer drug nearly doubled and the company raised its full-year profit outlook.
Stocks rally after US-EU trade deal
Trump-EU trade agreement